Company:  ORAMED PHARMACEUTICALS IN ... (ORMP)
Form Type:  10-Q
Filing Date:  7/14/2014 
CIK:  0001176309 
Address:  HI-TECH PARK 2/4 GIVAT-RAM
PO BOX 39098
 
City, State, Zip:  JERUSALEM,  91390 
Telephone:  011 972-2-566-0001 
Fiscal Year:  08/31 
Last Trade
Last Trade: 
$7.18  
Change: 
-0.22 (-2.97%)  
Trade Time: 
03:59 PM EST  
Market Cap: 
$71.48M
Description of Business
We are a pharmaceutical company currently engaged in the research and development of innovative pharmaceutical solutions, including an orally ingestible insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. Oral insulin: We are seeking to revolutionize the treatment of diabetes through our proprietary flagship product, an orally ingestible insulin capsule (ORMD0801) currently in non-U.S. Food and Drug Administration, or FDA, approved Phase 2 clinical trials. Our technology allows insulin to travel from the gastrointestinal tract via the portal vein to the bloodstream, revolutionizing the manner in which insulin is delivered. It enables its passage in a more physiological manner than current delivery methods of insulin. Our technology is a platform that has the potential to deliver medications and vaccines orally that today can only be delivered via injection.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I - FINANCIAL INFORMATION
      ITEM 1 - FINANCIAL STATEMENTS
        BALANCE SHEET
        BALANCE SHEET
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
      ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      ITEM 3 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      ITEM 4 - CONTROLS AND PROCEDURES
    PART II - OTHER INFORMATION
      ITEM 2 - UNREGISTERED SALES OF SECURITIES AND USE OF PROCEEDS.
      ITEM 6 - EXHIBITS
    SIGNATURES
  EXHIBIT 31.1
    CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
  EXHIBIT 31.2
    CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
  EXHIBIT 32.1
    CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
  EXHIBIT 32.2
    CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
BROKERAGE PARTNERS